We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors focused on the Medical space have likely heard of IDEXX Laboratories (IDXX - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
IDEXX Laboratories is one of 1045 individual stocks in the Medical sector. Collectively, these companies sit at #16 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. IDXX is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for IDXX's full-year earnings has moved 4.66% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that IDXX has returned about 35.35% since the start of the calendar year. At the same time, Medical stocks have lost an average of 1.37%. This means that IDEXX Laboratories is performing better than its sector in terms of year-to-date returns.
Breaking things down more, IDXX is a member of the Medical - Instruments industry, which includes 95 individual companies and currently sits at #180 in the Zacks Industry Rank. This group has gained an average of 12.28% so far this year, so IDXX is performing better in this area.
IDXX will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
Investors focused on the Medical space have likely heard of IDEXX Laboratories (IDXX - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
IDEXX Laboratories is one of 1045 individual stocks in the Medical sector. Collectively, these companies sit at #16 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. IDXX is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for IDXX's full-year earnings has moved 4.66% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that IDXX has returned about 35.35% since the start of the calendar year. At the same time, Medical stocks have lost an average of 1.37%. This means that IDEXX Laboratories is performing better than its sector in terms of year-to-date returns.
Breaking things down more, IDXX is a member of the Medical - Instruments industry, which includes 95 individual companies and currently sits at #180 in the Zacks Industry Rank. This group has gained an average of 12.28% so far this year, so IDXX is performing better in this area.
IDXX will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.